The Complete Guide to Getting Rezlidhia (Olutasidenib) Covered by UnitedHealthcare in New Jersey: Requirements, Appeals, and Step Therapy
Answer Box: Getting Rezlidhia Covered in New Jersey
UnitedHealthcare requires prior authorization for Rezlidhia (olutasidenib) in New Jersey, with specific requirements for documented IDH1 mutation and AML diagnosis. The fastest path: (1) Submit PA through the UnitedHealthcare Provider Portal with IDH1 mutation test results, (2) Include medical necessity letter addressing